Derma brands drive NIVEA turnaround plan
Beiersdorf’s latest half-year results paint a picture of a company navigating a complex landscape, where premium excellence shines brilliantly while the mass-market segment faces significant turbulence. While overall sales saw a slight dip, the performance breakdown reveals a powerful story of strategic resilience and ambitious future planning.
The numbers reveal a distinct divergence in performance. Group sales declined 3.5% organically to €5.0 billion during the first half of 2026, with consumer sales falling by 4.0%. This overall trend underscores the ongoing pressures facing the consumer goods sector, but it masks remarkable strength within the company’s highly specialized portfolio.
The real story lies in the performance of the Derma segment, which continues to outperform expectations. Brands like Eucerin and Aquaphor were engines of growth, delivering an impressive organic sales increase of 7.8%. This success was fueled by a commitment to innovation, highlighted by advancements such as Epicelline® and Thiamidol®, coupled with successful expansion across key international markets including North America, Brazil, and China.
Even within the broader portfolio, luxury reaffirmed its position. La Prairie successfully rebounded to growth in the second quarter following temporary retail disruptions, demonstrating the enduring appeal of high-end skincare solutions. Furthermore, Health Care brands like Hansaplast and Elastoplast also posted healthy growth of 4.0%.
In sharp contrast, NIVEA, Beiersdorf’s largest brand, experienced a notable organic sales decline of 6.8%. This dip was attributed to a combination of factors, including shifting customer preferences, delayed seasonal demand, ongoing trade destocking, and general weakness across parts of its core portfolio.
Recognizing this challenge, Beiersdorf has swiftly mobilized a comprehensive strategy designed not just to stabilize, but to reimagine the future of its most iconic brand. The company has launched an ambitious 18-month turnaround programme focused on fundamental changes: accelerating innovation, improving affordability and accessibility, increasing locally tailored product offerings, and investing an additional €100 million in consumer-facing marketing during the second half of 2026.
This strategic shift demonstrates that the company recognizes the balance between maintaining strong premium performance and the necessity of revitalizing its mass-market core. The focus is clearly on using innovation and targeted investment to restore momentum where it is most needed.
Looking ahead, Beiersdorf has revised its full-year outlook, expecting only a low-single-digit organic sales decline for the full year. Crucially, the company maintains an ambitious vision: achieving genuine sales growth in 2027 and securing profitable growth from 2028, setting a clear trajectory for sustained, future-focused expansion.
Buy on Amazon
Credit
